Skip to main content

Table 1 Ki67-expression/Necrosis (%) and Apoptosis (TUNEL test) in RMS xenografts treated with vehicle (DMSO), suberoylanilide hydroxamic acid (SAHA), irradiation (XRT), or SAHA and XRT in the first and second mouse cohort observed day 8 (cohort I) and day 21 (Cohort II)

From: In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

Treatment

Mean Tumor Age (days)

Mean (SD) Ki-67 (%)

HE (necrosis)(%)

TUNEL (apoptosis)

 

Cohort I Cohort II

Cohort I CohortII

Cohort I CohortII

Cohort I CohortII

Control

39 (± 3)

37

42 (± 16)

45 (± 12)

25 (± 11)

8 (± 6)

64 (± 9)

55 (± 9)

SAHA

36 (± 1)

37

53 (± 10)

32 (± 11)

23 (± 9)

10 (± 6)

118 (± 15)

97 (± 12)

XRT

36 (± 1)

37

21 (± 4)

24 (± 7)

42 (± 12)

10 (± 5)

148 (± 24)

126 (± 12)

SAHA + XRT

36 (± 1)

37

14 (± 8)

17 (± 4)

48 (± 17)

12 (± 6)

201 (± 11)

192 (± 10)